Series B - Iridia

Series B - Iridia

Investment Firm

Overview

Iridia is a nanotechnology company that specializes in bio-chemistry, molecular biology, and DNA.

Announced Date

Mar 16, 2021

Funding Type

Series B

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

N/A

Participant Investors

5

Investor Name
Participant InvestorValidus Growth Investors
Participant InvestorATEM Capital Fund LP
Participant InvestorWestern Digital Capital
Participant InvestorJSR
Participant InvestorTech Coast Angels

Round Details and Background

Iridia raised $24000000 on 2021-03-16 in Series B

Iridia is a nanotechnology company that specializes in bio-chemistry, molecular biology, and DNA.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 16, 2020
Venture Round - Iridia
-7.6M
Mar 16, 2021
Series B - Iridia
9-24.0M
Nov 15, 2021
Series B - Iridia
1-6.0M
Jun 06, 2017
Venture Round - Iridia
1-400.0K

Recent Activity

There is no recent news or activity for this profile.